Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival
Mustafa Beneklı, Meir Wetzler, Lynda A. Pixley(Roswell Park Comprehensive Cancer Center), Kathleen Donohue(Roswell Park Comprehensive Cancer Center), Laurie Ford(Roswell Park Comprehensive Cancer Center), Heinz Baumann(Roswell Park Comprehensive Cancer Center), Zheng Xia(Roswell Park Comprehensive Cancer Center), Maria R. Baer(University of Maryland, Baltimore)
Cited by 177
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
|Journal of Clinical Oncology|2010|764